Third Quarter Financial Report

15. Nov 2017 | 2 min read

Moss, 15 November 2017

Gentian Diagnostics AS announces its results for the third quarter. The highlights of the quarter include:

  • 66% growth in sales revenue compared to 3Q16, 16 % y/y
  • New patent protection received after end of period

Please find the report for the third quarter enclosed.

 

For further information, please contact:

Bård Sundrehagen CEO, Gentian Diagnostics
E-mail: Bard.sundrehagen@gentian.no
Cell Phone: +47 924 14 117

 
MeldingsID:  438711
 
 

You may also read


Mar 20, 2026 - Ole Sørlie

Gentian Diagnostics: Annual report 2025

Moss, 20 March 2026 Gentian Diagnostics has today published its annual report for 2025. The annual report and..

Read more

Mar 12, 2026 - Ole Sørlie

Gentian Diagnostics ASA – Mandatory notification of subscription of shares by primary insiders in Employee Share Purchase Program

Moss, 12 March 2026 Reference is made to Gentian Diagnostics ASA's (the "Company") stock exchange..

Read more

Mar 12, 2026 - Ole Sørlie

Gentian Diagnostics ASA – Employee Share Purchase Program and share capital increase

Moss, 12 March 2026 Gentian Diagnostics ASA (the "Company") has completed the offer of new shares to..

Read more